Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference

Key Takeaway: Viatris Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. The event will feature a presentation and a fireside chat, starting at 9 a.m. PT. A live webcast will be available, along with an archived version post-event. Viatris aims to bridge generics and brands to enhance global healthcare access.
Price reaction · baseline $11.46 (2025-12-16 close) · hit pre-market · 1 other VTRS headline(s) in the window, move may be shared
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is presenting at a significant healthcare conference.
  • The company showcases its commitment to global healthcare.
  • Live webcast allows broader access to the presentation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH,Dec. 17, 2025/PRNewswire/ --Viatris Inc. (Nasdaq:VTRS), a global healthcare company, today announced that the Company will present at the 44thAnnual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026. The Company's presentation and fireside chat will begin at 9 a.m. PT / 12 p.m. ET.
A live webcast of the event can be found atinvestor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.

About ViatrisViatris Inc.(Nasdaq:VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more atviatris.comandinvestor.viatris.com, and connect with us onLinkedIn,Instagram,YouTubeandX.

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris present at the conference?

Viatris will present on January 13, 2026, at 9 a.m. PT.

Where can I watch the Viatris presentation?

The presentation will be available via a live webcast at investor.viatris.com.

What is the focus of Viatris as a company?

Viatris aims to bridge the gap between generics and brands to improve global healthcare.

How many patients does Viatris serve annually?

Viatris supplies high-quality medicines to approximately 1 billion patients each year.

Last updated: Dec 17, 2025